Pharmacological models in healthy volunteers: their use in the clinical development of psychotropic drugs.
about
Biomarkers in development of psychotropic drugs.Use of translational pharmacodynamic biomarkers in early-phase clinical studies for schizophrenia.Effects of lorazepam on brain activity pattern during an anxiety symptom provocation challenge.Inhibition of cerebral type 1 cannabinoid receptors is associated with impaired auditory mismatch negativity generation in the ketamine model of schizophrenia.
P2860
Pharmacological models in healthy volunteers: their use in the clinical development of psychotropic drugs.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Pharmacological models in heal ...... lopment of psychotropic drugs.
@en
type
label
Pharmacological models in heal ...... lopment of psychotropic drugs.
@en
prefLabel
Pharmacological models in heal ...... lopment of psychotropic drugs.
@en
P2860
P356
P1476
Pharmacological models in heal ...... lopment of psychotropic drugs.
@en
P2093
Christian Gilles
Remy Luthringer
P2860
P304
P356
10.1177/0269881107077733
P407
P577
2007-05-01T00:00:00Z